While previous studies have shown that low CD4+ T lymphocytes promote anal squamous carcinoma progression but not colorectal adenocarcinoma progression [41], the cases included in this study were unable to receive curative chemoradiotherapy for various reasons and were treated with surgery as a salvage option. The gene discussed is CD4; the disease is colorectal adenocarcinoma.